Among the common pathways, PPAR signaling and metabolic pathways were highly significant in human NAFLD patients (Figure 7F) and BPA lineage females (Figure 7G), respectively. This evidence concerns the gene DST and metabolic dysfunction-associated steatotic liver disease.